Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Infective Endocarditis

Background. Recurrent therapeutic failures reported for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) with vancomycin may be due to poor bactericidal activity. Alternative antibacterial approaches using bacteriophages may overcome this limitation. Ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Save, Jonathan, Que, Yok-Ai, Entenza, José, Resch, Grégory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412893/
https://www.ncbi.nlm.nih.gov/pubmed/36016414
http://dx.doi.org/10.3390/v14081792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412893/
https://www.ncbi.nlm.nih.gov/pubmed/36016414
http://dx.doi.org/10.3390/v14081792

Ejemplares similares